The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

Not Applicable

Not yet recruiting

• Conditions: Corneal Diseases

• Registration Number: NCT06904560
• Lead Sponsor: Sohag University

Brief Summary

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Detailed Description

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Study Timeline

• Status Verified: 2025-03
• Study First Submitted: 2025-03-24
• Study First Submitted QC: 2025-03-28
• Last Update Submitted: 2025-03-28
• Study Start: 2025-04-01
• Study First Posted: 2025-04-01
• Last Update Posted: 2025-04-01
• Primary Completion: 2025-06-01
• Study Completion: 2025-07-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• patients with cataract
• more than 40 years
• no glaucoma
• no retinal abnormalities
• no retinal abnormalities

Exclusion Criteria

patients with corneal diseases patients less than 40 patients with previous eye surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
endothelial cell count	3 months

Secondary Outcome Measures

Name	Time	Method
incidence of anterior segment inflammation	3 months	incidence of anterior segment inflammation including conjunctival hypremia or corneal edema